Previous 10 | Next 10 |
Icon (NASDAQ:ICLR): Q3 GAAP EPS of -$1.17 misses by $2.55. Revenue of $1.87B (+166.5% Y/Y) beats by $30M. Press Release For further details see: Icon EPS misses by $2.55, beats on revenue
Highlights Record net business wins in the quarter of $2,374 million; a net book to bill of 1.27. Closing backlog of $18.6 billion, an increase of 3% on our Combined Company Backlog since the closing of the PRA acquisition on 1 July 2021, or an increase of 14% year ove...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy delivered positive returns and outperformed ...
After the recent era of value expansion due to the pandemic and fiscal policy, the use of unbiased rankings may allow for long-term success. As valuations come back down to historical levels, as very few would claim they will stay elevated perpetually, holding the right stocks will be...
Shares of ICON plc (NASDAQ:ICLR) traded today at $264.31, eclipsing its 52-week high. So far today approximately 107,000 shares have been exchanged, as compared to an average 30-day volume of 700,000 shares. Over the past year, ICON plc has traded in a range of $168.76 to $264.31 and is ...
Shares of ICON plc (NASDAQ:ICLR) traded today at $261.89, eclipsing its 52-week high. So far today approximately 107,000 shares have been exchanged, as compared to an average 30-day volume of 715,000 shares. Based on a current price of $261.83, ICON plc is currently 11.1% above its avera...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at: the Wells Fargo 16th Annual Healthcare Conference on Thursday, September 9, 2021 at 8.00am ET; and ...
The Fed’s creation of money is here to stay. U.S. inflation and debt monetization have fully engaged. 40 stocks I’d rather be in than government debt. One simple solution for trend identification that’s worked for more than 20 years in indices, currencies ...
Shares of ICON plc (NASDAQ:ICLR) traded today at $252.60, eclipsing its 52-week high. Approximately 107,000 shares have changed hands today, as compared to an average 30-day volume of 816,000 shares. Icon is a global late-stage contract research organization that provides drug developmen...
ICON Public Limited Company is a leading clinical research organization, aiding researchers and companies across the entire industry in performing their work. The healthcare industry is extremely strong at the moment and set to see favorable tailwinds over the next few years. I be...
News, Short Squeeze, Breakout and More Instantly...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the second quarter 2024 after the market closes on Wednesday, July 24, 2024. The company will hold a conference call and webcas...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 1:30pm ET. Any changes to this event and links...